Reducing the Global Burden of Cardiovascular Disease, Part 1

Philip Joseph(Population Health Research Institute), Salim Yusuf(Population Health Research Institute), Andrew Mente(Hamilton Health Sciences), Koon Teo(Population Health Research Institute), Jon-David Schwalm(Population Health Research Institute), Sonia S. Anand(Impact), Darryl P. Leong(Hamilton Health Sciences), Martin McKee(London School of Hygiene & Tropical Medicine)
Circulation Research
August 31, 2017
10.1161/circresaha.117.308903
Cited by 1,066

Related Papers

Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
|The Lancet|2005|2.9k
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
|New England Journal of Medicine|2017|2.4k
Patient safety, satisfaction, and quality of hospital care: cross sectional surveys of nurses and patients in 12 countries in Europe and the United States
|BMJ|2012|2k
ACC/AHA guidelines for coronary artery bypass graft surgery
|Journal of the American College of Cardiology|1999|2k